Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Successful bowel surgery at hemoglobin 2 g/dL without blood transfusion.

Padmakumar R, Pai M, Farish S, Rajeev J, Sanjeev T, Sreevalsan TV, Sheetal B, Sooraj YS, Rowther SS.

World J Gastrointest Surg. 2013 Aug 27;5(8):252-5. doi: 10.4240/wjgs.v5.i8.252.

2.

Isolation of dendritic cells from human blood for in vitro interaction studies with fungal antigens.

Sreevalsan T.

Methods Mol Biol. 2009;499:1-8. doi: 10.1007/978-1-60327-151-6_1.

PMID:
19152033
3.

Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells.

McCubrey JA, Shelton JG, Steelman LS, Franklin RA, Sreevalsan T, McMahon M.

Oncogene. 2004 Oct 14;23(47):7810-20.

PMID:
15361836
4.
5.
6.

Cell-cycle-specific and serum-dependent expression of gamma-actin mRNA in Swiss mouse 3T3 cells.

Masibay AS, Qasba PK, Sengupta DN, Damewood GP, Sreevalsan T.

Mol Cell Biol. 1988 Jun;8(6):2288-94.

7.

Potentiation of thermal injury in mouse cells by interferon.

Tumarkin L, Damewood GP 4th, Sreevalsan T.

Biochem Biophys Res Commun. 1985 Apr 16;128(1):179-84.

PMID:
2580529
8.

In vitro binding of Candida albicans yeast cells to human fibronectin.

Skerl KG, Calderone RA, Segal E, Sreevalsan T, Scheld WM.

Can J Microbiol. 1984 Feb;30(2):221-7.

PMID:
6370399
9.
10.

Tunicamycin enhances the antiviral and anticellular activity of interferon.

Maheshwari RK, Sreevalsan T, Silverman RH, Hay J, Friedman RM.

Science. 1983 Mar 18;219(4590):1339-41.

PMID:
6187067
11.
12.

Immunomodulatory activities of human leukocyte interferon in advanced cancer patients.

Bash JA, Teitelbaum D, Sreevalsan T, Neefe JR.

J Biol Response Mod. 1983;2(1):57-65.

PMID:
6606019
13.

Potentiation of radiation injury by interferon.

Dritschilo A, Mossman K, Gray M, Sreevalsan T.

Am J Clin Oncol. 1982 Feb;5(1):79-82.

PMID:
6177232
14.

Platelet interactions with Candida albicans.

Skerl KG, Calderone RA, Sreevalsan T.

Infect Immun. 1981 Dec;34(3):938-43.

15.
16.

Assay of effect of interferon on intracellular enzymes.

Sreevalsan T, Lee E, Friedman RM.

Methods Enzymol. 1981;79(Pt B):342-9. No abstract available.

PMID:
6173682
17.

Differential effect of interferon on ornithine decarboxylase activation in quiescent Swiss 3T3 cells.

Lee EJ, Larkin PC, Sreevalsan T.

Biochem Biophys Res Commun. 1980 Nov 17;97(1):301-8. No abstract available.

PMID:
6161615
18.
19.
20.

Correlation between the growth inhibitory effects, partition coefficients and teratogenic effects of lipophilic acids.

Freese E, Levin BC, Pearce R, Sreevalsan T, Kaufman JJ, Koski WS, Semo NM.

Teratology. 1979 Dec;20(3):413-40.

PMID:
120615
21.

Sindbis virus RNA replication. I. Properties of the 38s RNA species.

Czarniecki CW, Sreevalsan T.

J Gen Virol. 1979 Sep;44(3):759-71.

PMID:
528982
22.

Selective inhibition by interferon of serum-stimulated biochemical events in 3T3 cells.

Sreevalsan T, Taylor-Papadimitriou J, Rozengurt E.

Biochem Biophys Res Commun. 1979 Apr 13;87(3):679-85. No abstract available.

PMID:
454417
23.

California encephalitis virus: some biological and biochemical properties.

Goldman N, Presser I, Sreevalsan T.

Virology. 1977 Jan;76(1):352-64. No abstract available.

PMID:
835232
24.

Inhibitory effects of lipophilic acids and related compounds on bacteria and mammalian cells.

Sheu CW, Salomon D, Simmons JL, Sreevalsan T, Freese E.

Antimicrob Agents Chemother. 1975 Mar;7(3):349-63.

25.

Studies on the intracisternal A-type particles in mouse plasma cell tumors: induction of maturation of the particles.

Stewart SE, Kasnic G Jr, Urbanski C, Myers M, Sreevalsan T.

Ann N Y Acad Sci. 1975 Jan 27;243:172-84.

PMID:
1055537
26.

Sindbis virus replicative intermediates: purification and characterization.

Segal S, Sreevalsan T.

Virology. 1974 Jun;59(2):428-42. No abstract available.

PMID:
4833537
27.

Proteins specified by Sindbis virus in HeLa cells.

Snyder HW, Sreevalsan T.

J Virol. 1974 Feb;13(2):541-4.

28.

Inhibition of Sindbis virus replication in HeLa cells by poliovirus.

Sreevalsan T, Rosemond-Hornbeak H.

Antimicrob Agents Chemother. 1974 Jan;5(1):55-62.

29.

Growth inhibition and morphological changes caused by lipophilic acids in mammalian cells.

Ginsburg E, Salomon D, Sreevalsan T, Freese E.

Proc Natl Acad Sci U S A. 1973 Aug;70(8):2457-61.

30.

Proteins specified by Sindbis virus in chick embryo fibroblast cells.

Snyder HW, Sreevalsan T.

Biochem Biophys Res Commun. 1973 Jul 2;53(1):24-31. No abstract available.

PMID:
4795358
31.

Variable response of human cells to polyinosinic-polycytidylic acid.

Sreevalsan T.

Antimicrob Agents Chemother. 1973 May;3(5):642-4.

32.

Viral RNAs associated with ribosomes in Sindbis virus-infected HeLa cells.

Rosemond H, Sreevalsan T.

J Virol. 1973 Mar;11(3):399-415.

34.
35.
36.

Sindbis virus-induced viral ribonucleic acid polymerase.

Sreevalsan T, Yin FH.

J Virol. 1969 Jun;3(6):599-604.

38.
39.

Heterogeneous RNA's occurring during the replication of Western equine encephalomyelitis virus.

Sreevalsan T, Lockart RZ Jr.

Proc Natl Acad Sci U S A. 1966 Apr;55(4):974-81. No abstract available.

40.
41.

Attempts to obtain pure influenza virus in chorio-allantoic membrane cultures in vitro.

VEERARAGHAVAN N, NATARAJAN S, SREEVALSAN T.

Indian J Med Res. 1963 Jan;51:1-6. No abstract available.

PMID:
13996542
42.

Inhibition of viral RNA synthesis by interferon.

LOCKART RZ Jr, SREEVALSAN T, HORN B.

Virology. 1962 Nov;18:493-4. No abstract available.

PMID:
13931182
43.

A comparison of methods for interferon assay.

SREEVALSAN T, LOCKART RZ Jr.

Virology. 1962 May;17:207-8. No abstract available.

PMID:
13915990
44.

Evaluation of some methods of concentration and purification of influenza virus.

VEERARAGHAVAN N, SREEVALSAN T.

Bull World Health Organ. 1961;24:695-702.

45.

Attempts to increase the yield of influenza virus from stored infected allantoic fluids.

VEERARAGHAVAN N, SREEVALSAN T.

Bull World Health Organ. 1961;24:703-9.

46.

Studies on the cultivation of influenza virus in vitro.

VEERARAGHAVAN N, KIRTIKAR MW, SREEVALSAN T.

Bull World Health Organ. 1961;24:711-22.

Supplemental Content

Loading ...
Support Center